Clinical Trial Update: Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety study of CTx-1301 in adults with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Attention-deficit Hyperactivity Disorder Combined Type

Drugs mentioned

• CTx-1301

Snippet

Sponsor: Cingulate Therapeutics | Conditions: ADHD, ADHD - Combined Type | Phase 3 | Status: COMPLETED